Nomination Committee appointed for the Annual General Meeting 2027

By Cision
Essity

The Annual General Meeting of Essity adopted in 2020 instructions for the appointment of the Nomination Committee, which apply until the General Meeting resolves otherwise. According to these instructions, the company shall have a Nomination Committee consisting of members appointed by each of the four largest shareholders in terms of voting rights on the last banking day in August, as well as the Chairman of the Board of Directors, who shall convene the Committee.

The Nomination Committee has now been appointed and consists of the following members:
•    Helena Stjernholm, AB Industrivärden, Chairman of the Nomination Committee
•    Anders Hansson, AMF och AMF Fonder
•    Niko Pakalen, Cevian Capital Partners Ltd
•    Anders Jonsson, Livförsäkringsbolaget Skandia
•    Jan Gurander, Chairman of the Board of Directors of Essity

Ahead of the Annual General Meeting 2027, the Nomination Committee shall prepare proposals regarding the Chairman of the Meeting, the number of Board members, remuneration to each of the Board members, election of Board members and Chairman of the Board of Directors, remuneration to the auditor and election of auditor, and, to the extent deemed necessary, proposals for amendments to the instructions for the Nomination Committee.

The Annual General Meeting will be held on April 7, 2027, in Stockholm.

Shareholders who wish to submit proposals to the Nomination Committee ahead of the Annual General Meeting 2027 may do so to the secretary of the Nomination Committee, General Counsel Mikael Schmidt, by email: mikael.schmidt@essity.com. In order for submitted proposals to be handled in a constructive manner, they should be received by the Nomination Committee no later than December 31, 2026.

Stockholm, September 23, 2026
Essity Aktiebolag (publ)

For additional information, please contact:
Per Lorentz, Vice President Corporate Affairs, +46 73 313 30 55, per.lorentz@essity.com
Sandra Åberg, Vice President Investor Relations, +46 70 564 96 89, sandra.aberg@essity.com 

Essity is a global, leading hygiene and health company. Every day, our products, solutions and services are used by a billion people around the world. Our purpose is to break barriers to well-being for the benefit of consumers, patients, caregivers, customers and society. Sales are conducted in approximately 150 countries under the leading global brands TENA and Tork, and other strong brands such as Actimove, Cutimed, JOBST, Knix, Leukoplast, Libero, Libresse, Lotus, Modibodi, Nosotras, Saba, Tempo, TOM Organic and Zewa. In 2025, Essity had net sales of approximately SEK 138bn (EUR 13bn) and employed 36,000 people. The company's headquarters is located in Stockholm, Sweden and Essity is listed on Nasdaq Stockholm. More information at essity.com.

https://news.cision.com/essity/r/nomination-committee-appointed-for-the-annual-general-meeting-2027%2Cc4399667

Nomination Committee appointed for the Annual General Meeting 2027

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.